Deciphera Pharmaceuticals, Inc. Operating Cash Flow
Deciphera Pharmaceuticals, Inc. reported Operating Cash Flow of -$54.59 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-05-10
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-03-31 was -$54.59M.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$28.81M.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was -$29.81M.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$38.63M.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$146.70M.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$152.86M.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$240.82M.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$239.68M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$54.59M 10-Q · filed 2024-05-10 | -$83.39M derived: sum of 2 quarters · filed 2024-05-10 | -$113.20M derived: sum of 3 quarters · filed 2024-05-10 | -$151.83M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-12-31 | -$28.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | -$58.62M derived: sum of 2 quarters · filed 2024-02-07 | -$97.24M derived: sum of 3 quarters · filed 2024-02-07 | -$146.70M 10-K · filed 2024-02-07 |
| 2023-09-30 | -$29.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | -$68.43M derived: sum of 2 quarters · filed 2023-10-30 | -$117.89M 10-Q · filed 2023-10-30 | -$153.05M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-06-30 | -$38.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$88.08M 10-Q · filed 2023-08-09 | -$123.24M derived: sum of 3 quarters · filed 2024-05-10 | -$144.07M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-03-31 | -$49.45M 10-Q · filed 2024-05-10 | -$84.61M derived: sum of 2 quarters · filed 2024-05-10 | -$105.44M derived: sum of 3 quarters · filed 2024-05-10 | -$150.97M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$35.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | -$55.99M derived: sum of 2 quarters · filed 2024-02-07 | -$101.51M derived: sum of 3 quarters · filed 2024-02-07 | -$152.86M 10-K · filed 2024-02-07 |
| 2022-09-30 | -$20.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | -$66.35M derived: sum of 2 quarters · filed 2023-10-30 | -$117.70M 10-Q · filed 2023-10-30 | -$184.88M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | -$45.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$96.88M 10-Q · filed 2023-08-09 | -$164.05M derived: sum of 3 quarters · filed 2024-02-07 | -$218.05M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | -$51.35M 10-Q · filed 2023-05-03 | -$118.53M derived: sum of 2 quarters · filed 2024-02-07 | -$172.53M derived: sum of 3 quarters · filed 2024-02-07 | -$224.49M derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | -$67.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | -$121.17M derived: sum of 2 quarters · filed 2024-02-07 | -$173.14M derived: sum of 3 quarters · filed 2024-02-07 | -$240.82M 10-K · filed 2024-02-07 |
| 2021-09-30 | -$54.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$105.97M derived: sum of 2 quarters · filed 2022-11-03 | -$173.65M 10-Q · filed 2022-11-03 | -$222.78M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | -$51.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$119.65M 10-Q · filed 2022-08-04 | -$168.78M derived: sum of 3 quarters · filed 2023-02-07 | -$218.12M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | -$67.68M 10-Q · filed 2022-05-04 | -$116.81M derived: sum of 2 quarters · filed 2023-02-07 | -$166.15M derived: sum of 3 quarters · filed 2023-02-07 | -$227.00M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | -$49.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | -$98.47M derived: sum of 2 quarters · filed 2023-02-07 | -$159.31M derived: sum of 3 quarters · filed 2023-02-07 | -$239.68M 10-K · filed 2023-02-07 |
| 2020-09-30 | -$49.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$110.19M derived: sum of 2 quarters · filed 2021-11-02 | -$190.56M 10-Q · filed 2021-11-02 | -$246.39M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | -$60.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$141.21M 10-Q · filed 2021-08-03 | -$197.05M derived: sum of 3 quarters · filed 2022-02-08 | -$220.24M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | -$80.37M 10-Q · filed 2021-05-04 | -$136.20M derived: sum of 2 quarters · filed 2022-02-08 | -$159.39M derived: sum of 3 quarters · filed 2022-02-08 | -$196.66M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | -$55.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | -$79.02M derived: sum of 2 quarters · filed 2022-02-08 | -$116.29M derived: sum of 3 quarters · filed 2022-02-08 | -$149.30M 10-K · filed 2022-02-08 |
| 2019-09-30 | -$23.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$60.46M derived: sum of 2 quarters · filed 2020-11-05 | -$93.46M 10-Q · filed 2020-11-05 | -$120.33M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | -$37.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$70.27M 10-Q · filed 2020-08-04 | -$97.14M derived: sum of 3 quarters · filed 2021-02-09 | -$122.07M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | -$33.01M 10-Q · filed 2020-05-05 | -$59.87M derived: sum of 2 quarters · filed 2021-02-09 | -$84.81M derived: sum of 3 quarters · filed 2021-02-09 | -$103.09M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | -$26.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | -$51.80M derived: sum of 2 quarters · filed 2021-02-09 | -$70.09M derived: sum of 3 quarters · filed 2021-02-09 | -$86.78M 10-K · filed 2021-02-09 |
| 2018-09-30 | -$24.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$43.22M derived: sum of 2 quarters · filed 2019-11-04 | -$59.91M 10-Q · filed 2019-11-04 | -$72.67M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-06-30 | -$18.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | -$34.98M 10-Q · filed 2019-08-02 | -$47.74M derived: sum of 3 quarters · filed 2020-03-09 | -$56.60M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-03-31 | -$16.69M 10-Q · filed 2019-05-09 | -$29.45M derived: sum of 2 quarters · filed 2020-03-09 | -$38.31M derived: sum of 3 quarters · filed 2020-03-09 | |
| 2017-12-31 | -$12.75M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | -$21.62M derived: sum of 2 quarters · filed 2020-03-09 | -$36.70M 10-K · filed 2020-03-09 | |
| 2017-09-30 | -$8.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$23.95M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | -$15.08M 10-Q · filed 2018-08-07 | |||
| 2016-12-31 | -$23.09M 10-K · filed 2019-03-14 |